Understanding 21 CFR Part 11
FDA 21 CFR Part 11 was established in 1997 to provide criteria for acceptance of electronic records and electronic signatures. The regulation applies to all FDA-regulated industries where electronic records are used to meet FDA requirements.
Scope of the Regulation
The regulation applies to records that are:
- Created, modified, maintained, archived, retrieved, or transmitted in electronic form
- Required by FDA predicate rules
- Submitted electronically to the FDA
Key Technical Requirements
Closed System Controls (11.10): Organizations using closed systems must employ procedures and controls including validation, audit trails, system access limitations, and device checks.
Open System Controls (11.30): Additional controls are required for open systems, including encryption and digital signatures.
Electronic Signatures (Subpart C): Electronic signatures must be unique to one individual, subject to identity verification before assignment, and linked to their respective electronic records so that signatures cannot be excised, copied, or otherwise transferred to falsify a record.
How ATEK Supports Compliance
ATEK’s environmental monitoring platform is purpose-built for regulated industries. Our system provides the technical controls required by 21 CFR Part 11 while maintaining ease of use for your team.
Validation Support
We provide comprehensive validation documentation to support your qualification activities:
- Installation Qualification (IQ) protocols
- Operational Qualification (OQ) protocols
- Performance Qualification (PQ) templates
- Validation summary reports
Continuous Compliance
Unlike point-in-time compliance solutions, ATEK provides continuous compliance through:
- Real-time monitoring with automated alerts
- Immutable audit trails for all system activities
- Regular platform updates that maintain compliance
- Ongoing validation support with each release